
- Overall, MEA Pharmaceutical Business has reached $36.82 B value and 8.87 B Units Value sales growth has been at 16.5% PPG1 (Previous Period Growth) and 12.0% CAGR while Volume sales has increased at 2.0% PPG & at 2.9% CAGR
- Retail channel dominates the MEA Region with 67.3% ($24.76 B) share in value sales with 14.9% PPG and volume share of 81.6% (7.2 B Units) with 2.75% PPG
- Growth of Hospital channel has increased in terms of PPG 20.1% in value and decreased by -1.36% PPG in volume
- MNCs lead with 57.73% share in total value sales with 12.86% PPG
- Local companies have grown at 21.96% PPG in value and 3.94% PPG in volume
- Sanofi, Novartis and GSK continue to be the top MNC corporations in MEA contributing 23.3% to total MNC Sales
- Amongst the top 10 corporation, Eli Lilly is the fastest growing corporation growing at 59.2% PPG
- Alimentary Tract, Metabolism is the top TA holding 20.4% of value share with the highest contribution share from KSA at 37.5%
- Saudi Arabia has grown by 19.1% PPG, making it the fastest growing country in MEA, with sales valued at $13.8 B
- Hospital channel (Hospitals + LPO) grew by 22.9% PPG and accounting for 50.6% of total sales
- Top 10 corporations account for 44.1% share in sales.
- Hikma Pharma is leading with 6.4% share and 22.6% PPG
- Tabuk (35.0% PPG) is the fastest growing Local/Reg corp mainly driven by top brands like Ivarin (19.6%), Omiz (23.0%), Rapidus (4.1%) and Herox (12.4%) on PPG
- Egypt volume sales has declined reached to $4.8 B sales by -3% PPG driven by growth from Retail channel (0.79% PPG) accounting for 82.3% of country’s Units sales
- Systemic Antibacterials is the top TA in Egypt with 10.4% Units share while Dermatological Anti-Infectives (7.4% PPG) is the fastest growing amongst the top 10 TAs •
- Top 10 corporations account for 42.6% share in volume sales,
- Pharco is leading the sales with 7.8% share
- Apex is the fastest growing corporation among top 10 corps (38% PPG)
- UAE grew by 14% PPG (2nd fastest growing country in MEA region) accounting for $4.7 B sales
- Top 10 TAs account for 49.7% of total sales, wherein Newer Gen Type II Antidiabetics TA is growing at 30.5% PPG
- Top 10 corporations account for 48% share in sales with Eli Lilly being the fastest growing at 42% PPG; mainly driven by top brands like Mounjaro (58.9%), Cialis (10.4%), and Taltz (17.4%) on PPG
